openPR Logo
Press release

Burgeoning Demand for Citicoline Promises Higher Revenue Share Steered by Increased Manufacturer Support, details Fact.MR study | Key Players- Alfa Aesar, Cepham, Inc., EZ Melts, HL-Pharma US, Double Wood LLC, Instas Pharmaceuticals Ltd., Jarrow Formulas

06-21-2019 11:17 AM CET | Health & Medicine

Press release from: Fact.MR

Burgeoning Demand for Citicoline Promises Higher Revenue Share

According to a recent research by Fact.MR, the citicoline market is estimated to surpass US$ 550 million in 2019. Citicoline demand is driven by a range of factors, notably increasing geriatric population and growing use among eSports players. The study offers in-depth and incisive insights on key factors influencing the global demand for citicoline.

Supplement Consumption Among eSports Players: A Lucrative Opportunity

Growing popularity and increasing investments in eSports is helping the market go mainstream which, in turn, is opening an assortment of opportunities for various industries. Players participating in eSports tournaments are seeking cognitive enhancing supplements which can help them concentrate, plot strategies, and improve working memory. Additionally, a ban on the use of other nootropics such as Ritalin and Adderall in eSports leagues is creating demand for ‘permissible’ supplements. Citicoline’s negligible toxicity and its organic nature is making it an appealing prospect for eSports players. With regulations allowing the use of citicoline in functional food and supplements, manufacturers are increasingly focusing towards including the compound in their products to capitalize on the bolstering demand for cognitive-enhancing supplements in eSports.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2868

Citicoline’s Role in Ischemic Stroke Treatment Creating Opportunities

The adverse and often fatal impact of ischemic stroke on human health, coupled with increasing prevalence is bolstering demand for effective treatment of the condition. According to WHO, stroke is the second leading cause of death in the world and the third leading cause of disabilities in adults. Additionally, the lack of a standard procedure of treatment for different ischemic stroke patients is influencing healthcare researchers to focus on the development of acute therapy for all patients. According to Fact.MR’s study, citicoline is being viewed as a potential treatment option by researchers and healthcare providers. These factors are vital to citicoline market growth and are expected propel proliferation during the forecast period.

To know the latest trends and insights prevalent in this market, click @ https://www.factmr.com/report/2868/citicoline-market

The study opines that citicoline demand is also likely to be influenced by its role in treatment of brain injuries. Studies suggest treatment of patients with citicoline has been beneficial in reducing headaches, dizziness, tinnitus, and in substantially relieving motor, cognitive, and mental symptoms. These developments are further driving researchers towards testing its potential use in treatment for pervasive developmental disorders such as atypical autism, Asperger Syndrome, and autism. Intensifying clinical trials and research and developmental activities in the area are expected to open new and lucrative opportunities for companies in the citicoline market.

Increasing Demand for Memory-boosting Supplements for Elderly to Bolster Market Growth

The growth in the geriatric population around the world is expected to continue with the Population Reference Bureau (PRB) estimating the number of people aged over 65 to account for 16 percent of the world population by 2050. Citicoline finds widespread usage in the production of supplements for enhancing cognition in the elderly. In addition, intensifying clinical trials towards improving citicoline efficacy through its synergy with other chemicals is another vital factor estimated to drive market growth. Fact.MR opines that advancements in tablet manufacturing will bolster production of highly effective supplements, with sales of citicoline tablets estimated to reach nearly US$ 235 million in 2019.  

The Fact.MR report tracks the citicoline market for the period 2018-2028. According to the report, the citicoline market is projected to grow at 8.5% CAGR through 2028.

Ask Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=2868

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Burgeoning Demand for Citicoline Promises Higher Revenue Share Steered by Increased Manufacturer Support, details Fact.MR study | Key Players- Alfa Aesar, Cepham, Inc., EZ Melts, HL-Pharma US, Double Wood LLC, Instas Pharmaceuticals Ltd., Jarrow Formulas here

News-ID: 1783906 • Views:

More Releases from Fact.MR

Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players include Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharmaceuticals, IBA Group, IBA Radiopharma Solutions, Lantheus Medical Imaging
10-01-2025 | Health & Medicine
Fact.MR
Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players inclu …
The global muscle stimulators market is set for significant expansion, with its valuation expected to increase from USD 1.43 billion in 2025 to USD 2.92 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 7.4% over the forecast period from 2025 to 2035. The market's robust trajectory is driven by rising awareness of health and fitness, technological advancements in rehabilitation devices, and the increasing prevalence
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Becton, Dickinson and Company, Betterlifehealthcare Ltd., Cadwell Industries, Inc., Compumedics Ltd., GlaxoSmithKline, Inc., Hill-Rom Holdings
10-01-2025 | Health & Medicine
Fact.MR
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Be …
Fact.MR today unveiled its latest report on the Sleeping Aids Market, forecasting robust growth amid escalating sleep disorders, heightened stress levels, and a global push for restorative wellness solutions. Valued at USD 78.3 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching USD 131.3 billion by 2035. This trajectory reflects the market's pivotal role in addressing widespread insomnia, sleep
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; Salesforce; SAS; Oracle; Acoustic; Act-on Software; SendinBlue
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; …
The global marketing automation market is experiencing robust growth, valued at USD 6.83 billion in 2024 and forecasted to reach USD 26.68 billion by 2034. This expansion reflects a compound annual growth rate (CAGR) of 14.6% over the forecast period from 2024 to 2034. The surge is primarily driven by the escalating demand for targeted advertising, enhanced user retention, and data-backed strategies in digital marketing channels. As internet penetration and
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, Driven by Digital Transformation and Hybrid Work Trends
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, …
The global Integrated Workplace Management System (IWMS) market is experiencing significant growth, with projections indicating an increase from approximately USD 4 billion in 2024 to USD 10.6 billion by 2034, reflecting a compound annual growth rate (CAGR) of 10.2% over the period from 2025 to 2034. This expansion is attributed to the rising demand for automation in facility management, the adoption of digital workplace solutions, and the need for efficient

All 5 Releases


More Releases for Citicoline

Citicoline Market : Revenue Share, Insights & Future Outlook
What Is the Growth Forecast for the Global Citicoline Market by 2031? In 2024, the global Citicoline market was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 979 million by 2031, growing at a CAGR of 14.4% during the forecast period 2025-2031. Download Free Data: https://reports.valuates.com/request/sample/QYRE-Auto-222/Global_Citicoline_Market?utm_source=Openpr&utm_medium=Referral&utm_campaign=Citicoline_Market This significant growth reflects increasing demand in healthcare applications and expanding pharmaceutical usage across major global regions. How Is the Citicoline Market
Citicoline Market Study, Competition Analysis, Industry Trends, Research Report
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on citicoline market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound
Citicoline market grows with a CAGR of 13.8% during 2023-2029
The global Citicoline market size was valued at USD 304.6 million in 2022 and is forecast to a readjusted size of USD 751.9 million by 2029 with a CAGR of 13.8% during review period. In a groundbreaking study, the Healthcare Research Institute (HRI) presents an in-depth analysis of the Citicoline Market, shedding light on its current state, key players, segmentation, regional dynamics, and future projections. Citicoline, a vital compound renowned
Citicoline Market Size, Industry Share, Forecast 2026
Latest Updated Report 2023, The Global Citicoline Market to Growing A CAGR of % during forecast period of 2023-2026. The Market is segmented by Global Citicoline Market Breakdown by Application (Pharma, Non-pharma) by Type (Injection, Tablets, Capsule) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Citicoline Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the
Citicoline Market Competitive Landscape, Growth Factors, Revenue Analysis by 202 …
The Citicoline Market is expected to grow at a CAGR of 8% during the forecast period of 2023 to 2029. Citicoline induces the formation of phospholipids in the brain that are required for efficient functioning of the neural pathways. With incidences of dementia, Alzheimer's disease, and other neurological disorders on the rise, governments around the world are providing pharmaceutical companies extended support towards the research and development of drugs that could
Citicoline Market | CAGR of 14.4%
The global Citicoline Market 2020 Report provides fine intelligence that helps market players to compete well against the tough competition on the basis of growth, sales and other various important factors. The research report lays stress on key growth opportunities and market trends apart from important market dynamics including market drivers and challenges. With the help of this report, involved parties can equip themselves to adapt along with the changes